Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion.
Proc Natl Acad Sci U S A. 2021 Mar 9;118(10):e2000915118. doi: 10.1073/pnas.2000915118.
Proc Natl Acad Sci U S A. 2021.
PMID: 33649199
Free PMC article.